Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jansen

Showing results (1411-1420 of 1,668) with videos related to

Pageof 167
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 16, 2006
Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohortsW K Al-Delaimy, E H J M Jansen, P H M Peeters, et al.
European Radiology|October 26, 2013
Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and CAnneloes E Bohte, Annikki de Niet, Louis Jansen, et al.
Biochemical Pharmacology|August 30, 2022
A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancerL Wester, S Venneker, M Hazenoot, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2025
A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatmentRomy M van Amelsfoort, Patrick González, Rita Simões, et al.
Neuropsychiatric Disease and Treatment|July 1, 2025
A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMARTUrska Arnautovska, Gabrielle Ritchie, Rebecca Soole, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS TrialRomy M van Amelsfoort, Iris Walraven, Jacobien Kieffer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth HormoneA van Teunenbroek, S M de Muinck Keizer-Schrama, T Stijnen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 22, 1999
Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trialT C Sas, S M de Muinck Keizer-Schrama, T Stijnen, et al.
Journal of Medicinal Chemistry|October 24, 2008
Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitorsSavithri Ramurthy, Sharadha Subramanian, Mina Aikawa, et al.
Oncotarget|May 12, 2020
Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cellsLacey M Litchfield, Karsten Boehnke, Manisha Brahmachary, et al.
Pageof 167

Showing results (1411-1420 of 1,668) with videos related to

Sort By:
Pageof 167
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 16, 2006
Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohortsW K Al-Delaimy, E H J M Jansen, P H M Peeters, et al.
European Radiology|October 26, 2013
Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and CAnneloes E Bohte, Annikki de Niet, Louis Jansen, et al.
Biochemical Pharmacology|August 30, 2022
A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancerL Wester, S Venneker, M Hazenoot, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2025
A novel approach to assess the prognostic value of toxicity profiles in gastric cancer patients undergoing preoperative treatmentRomy M van Amelsfoort, Patrick González, Rita Simões, et al.
Neuropsychiatric Disease and Treatment|July 1, 2025
A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMARTUrska Arnautovska, Gabrielle Ritchie, Rebecca Soole, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS TrialRomy M van Amelsfoort, Iris Walraven, Jacobien Kieffer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth HormoneA van Teunenbroek, S M de Muinck Keizer-Schrama, T Stijnen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 22, 1999
Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trialT C Sas, S M de Muinck Keizer-Schrama, T Stijnen, et al.
Journal of Medicinal Chemistry|October 24, 2008
Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitorsSavithri Ramurthy, Sharadha Subramanian, Mina Aikawa, et al.
Oncotarget|May 12, 2020
Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cellsLacey M Litchfield, Karsten Boehnke, Manisha Brahmachary, et al.
Pageof 167